Related Experiment Video

Updated: Aug 29, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

[Tuberculosis in African children: epidemiologic, clinical and therapeutic aspects (corrected)]

R Anane1

  • 1Service de pédiatrie, CHU Bab El Oued, Alger, Algérie. tanane@ibnsina.ands.dz

Medecine Tropicale : Revue Du Corps De Sante Colonial
|February 7, 2004
PubMed

Insights

Diagnosing childhood tuberculosis (TB) is challenging. This study found that 6-month short-course chemotherapy is effective and well-tolerated in Algerian children, improving compliance and reducing complications.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Context:

  • Tuberculosis (TB) re-emerged as a global emergency, prompting WHO-recommended control strategies.
  • National TB control programs are essential due to rising cases and the HIV epidemic.
  • Diagnosing TB in children and estimating prevalence are particularly difficult.

Purpose:

  • To analyze diagnostic criteria for tuberculosis in 1128 children in Algiers, Algeria.
  • To evaluate the effectiveness and safety of short-course chemotherapy for childhood TB.

Summary:

  • A prospective study of 733 children demonstrated that 6-month short-course chemotherapy regimens are effective within a national program.
  • This treatment approach resulted in few complications and improved patient compliance.
  • The study also addressed prophylactic treatment for child contacts and adverse reactions to the BCG vaccine.

Impact:

  • Provides evidence for effective and well-tolerated short-course chemotherapy in childhood TB management.
  • Informs national TB control programs on optimizing treatment strategies for pediatric populations.
  • Highlights the importance of considering diagnostic challenges and prophylactic measures in pediatric TB control efforts.

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: